Detalhe da pesquisa
1.
Identification of the genetic mechanism that associates L3MBTL3 to multiple sclerosis.
Hum Mol Genet
; 31(13): 2155-2163, 2022 07 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35088080
2.
Emulating randomised clinical trials in relapsing-remitting multiple sclerosis with non-randomised real-world evidence: an application using data from the MSBase Registry.
J Neurol Neurosurg Psychiatry
; 2024 Jan 19.
Artigo
Inglês
| MEDLINE | ID: mdl-38242680
3.
Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 95(5): 410-418, 2024 Apr 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37940409
4.
No evidence for association between rs10191329 severity locus and longitudinal disease severity in 1813 relapse-onset multiple sclerosis patients from the MSBase registry.
Mult Scler
; : 13524585241240406, 2024 Mar 21.
Artigo
Inglês
| MEDLINE | ID: mdl-38511853
5.
Not all roads lead to the immune system: the genetic basis of multiple sclerosis severity.
Brain
; 146(6): 2316-2331, 2023 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36448302
6.
The risk of secondary progressive multiple sclerosis is geographically determined but modifiable.
Brain
; 146(11): 4633-4644, 2023 11 02.
Artigo
Inglês
| MEDLINE | ID: mdl-37369086
7.
Multifaceted Analysis of Cerebrospinal Fluid and Serum from Progressive Multiple Sclerosis Patients: Potential Role of Vitamin C and Metal Ion Imbalance in the Divergence of Primary Progressive Multiple Sclerosis and Secondary Progressive Multiple Sclerosis.
J Proteome Res
; 22(3): 743-757, 2023 03 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36720471
8.
Risk of secondary progressive multiple sclerosis after early worsening of disability.
J Neurol Neurosurg Psychiatry
; 94(12): 984-991, 2023 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37414538
9.
Heterogeneity on long-term disability trajectories in patients with secondary progressive MS: a latent class analysis from Big MS Data network.
J Neurol Neurosurg Psychiatry
; 94(1): 23-30, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36171104
10.
Disability accrual in primary and secondary progressive multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 94(9): 707-717, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37068931
11.
Effectiveness of multiple disease-modifying therapies in relapsing-remitting multiple sclerosis: causal inference to emulate a multiarm randomised trial.
J Neurol Neurosurg Psychiatry
; 94(12): 1004-1011, 2023 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37414534
12.
Prediction of relapse activity when switching to cladribine for multiple sclerosis.
Mult Scler
; 29(1): 119-129, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35894247
13.
Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis.
Mult Scler
; 29(7): 875-883, 2023 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-36851894
14.
Comparative effectiveness in multiple sclerosis: A methodological comparison.
Mult Scler
; 29(3): 326-332, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36800908
15.
Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis.
Eur J Neurol
; 30(4): 1014-1024, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36692895
16.
Assessment of the treating physicians' first-hand experience with handling and satisfaction of ofatumumab therapy: findings from the PERITIA survey conducted in Europe.
BMC Neurol
; 23(1): 147, 2023 Apr 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37038104
17.
Early predictors of disability in paediatric multiple sclerosis: evidence from a multi-national registry.
J Neurol Neurosurg Psychiatry
; 2022 Sep 30.
Artigo
Inglês
| MEDLINE | ID: mdl-36180218
18.
Prediction of multiple sclerosis outcomes when switching to ocrelizumab.
Mult Scler
; 28(6): 958-969, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-34623947
19.
Multiple Sclerosis Severity Score (MSSS) improves the accuracy of individualized prediction in MS.
Mult Scler
; 28(11): 1752-1761, 2022 10.
Artigo
Inglês
| MEDLINE | ID: mdl-35373638
20.
Confirmed disability progression as a marker of permanent disability in multiple sclerosis.
Eur J Neurol
; 29(8): 2321-2334, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35582938